Quick Takeaways
- Carrie S. Cox has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $14,115,366.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Carrie S. Cox
- Location
- Kenilworth, NJ
- Summary
- The estimated net worth of Carrie S. Cox is at least $14,115,366 dollars as of 30 Mar 2026. Carrie S. Cox is the Director of TEXAS INSTRUMENTS INC and owns shares of TEXAS INSTRUMENTS INC (TXN) stock worth about $6.53M. Carrie S. Cox is the Director of CARDINAL HEALTH INC and owns shares of CARDINAL HEALTH INC (CAH) stock worth about $4.46M. Carrie S. Cox is the Director of Solventum Corp and owns shares of Solventum Corp (SOLV) stock worth about $1.73M. Carrie S. Cox is the Executive Chair, Director of Organon & Co. and owns shares of Organon & Co. (OGN) stock worth about $1.34M. Carrie S. Cox is the Director of Cartesian Therapeutics, Inc. and owns shares of Cartesian Therapeutics, Inc. (RNAC) stock worth about $57.9K.
- Signature
- /s/Megan Bombick, attorney-in-fact for Carrie S. Cox
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Carrie S. Cox and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: TEXAS INSTRUMENTS INC ($6,527,734).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Carrie S. Cox
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| TXN | TEXAS INSTRUMENTS INC | Director | $6,527,734 | 29 Jan 2026 | ||
| CAH | CARDINAL HEALTH INC | Director | $4,457,847 | 09 Nov 2022 | ||
| SOLV | Solventum Corp | Director | $1,731,213 | 27 Mar 2026 | ||
| OGN | Organon & Co. | Executive Chair, Director | $1,340,676 | +$602,347 | +82% | 12 Nov 2025 |
| RNAC | Cartesian Therapeutics, Inc. | Director | $57,896 | 02 Jan 2025 |
Insider Transactions Reported by Carrie S. Cox:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.